Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Altered steroid milieu in AI resistant breast cancer facilitates AR mediated gene expression associated with poor response to therapy.

Creevey L, Bleach R, Madden SF, Toomey S, Bane FT, Varešlija D, Hill AD, Young LS, McIlroy M.

Mol Cancer Ther. 2019 Jul 9. pii: molcanther.0791.2018. doi: 10.1158/1535-7163.MCT-18-0791. [Epub ahead of print]

PMID:
31289138
2.

The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology.

Bleach R, McIlroy M.

Front Endocrinol (Lausanne). 2018 Oct 26;9:594. doi: 10.3389/fendo.2018.00594. eCollection 2018. Review.

3.

S100β as a serum marker in endocrine resistant breast cancer.

Charmsaz S, Hughes É, Bane FT, Tibbitts P, McIlroy M, Byrne C, Cocchiglia S, McBryan J, Hennessy BT, Dwyer RM, Kerin MJ, Hill AD, Young LS.

BMC Med. 2017 Apr 12;15(1):79. doi: 10.1186/s12916-017-0836-2.

4.

Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.

Ali A, Creevey L, Hao Y, McCartan D, O'Gaora P, Hill A, Young L, McIlroy M.

Breast Cancer Res. 2015 Sep 4;17:123. doi: 10.1186/s13058-015-0636-6.

5.

Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.

McBryan J, Fagan A, McCartan D, Bane FT, Varešlija D, Cocchiglia S, Byrne C, Bolger J, McIlroy M, Hudson L, Tibbitts P, Gaora PÓ, Hill AD, Young LS.

Clin Cancer Res. 2015 Dec 1;21(23):5371-9. doi: 10.1158/1078-0432.CCR-14-2155. Epub 2015 Aug 3.

6.

Relative value of oral health in well-child care: a survey of pediatricians in Texas and Ohio.

Hinze ES, Casamassimo PS, Seale NS, McIlroy M, Kerins CA, McWhorter AG.

J Dent Child (Chic). 2014 May-Aug;81(2):84-90.

PMID:
25198951
7.

Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer.

Pathiraja TN, Nayak SR, Xi Y, Jiang S, Garee JP, Edwards DP, Lee AV, Chen J, Shea MJ, Santen RJ, Gannon F, Kangaspeska S, Jelinek J, Issa JP, Richer JK, Elias A, McIlroy M, Young LS, Davidson NE, Schiff R, Li W, Oesterreich S.

Sci Transl Med. 2014 Mar 26;6(229):229ra41. doi: 10.1126/scitranslmed.3008326.

8.

Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis.

Walsh CA, Bolger JC, Byrne C, Cocchiglia S, Hao Y, Fagan A, Qin L, Cahalin A, McCartan D, McIlroy M, O'Gaora P, Xu J, Hill AD, Young LS.

Cancer Res. 2014 May 1;74(9):2533-44. doi: 10.1158/0008-5472.CAN-13-2133. Epub 2014 Mar 19.

9.

AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.

O'Hara J, Vareslija D, McBryan J, Bane F, Tibbitts P, Byrne C, Conroy RM, Hao Y, Gaora PÓ, Hill AD, McIlroy M, Young LS.

Clin Cancer Res. 2012 Jun 15;18(12):3305-15. doi: 10.1158/1078-0432.CCR-11-3300. Epub 2012 May 1.

10.

Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.

McCartan D, Bolger JC, Fagan A, Byrne C, Hao Y, Qin L, McIlroy M, Xu J, Hill AD, Gaora PÓ, Young LS.

Cancer Res. 2012 Jan 1;72(1):220-9. doi: 10.1158/0008-5472.CAN-11-1976. Epub 2011 Nov 9.

11.

RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer.

Flavin P, Redmond A, McBryan J, Cocchiglia S, Tibbitts P, Fahy-Browne P, Kay E, Treumann A, Perrem K, McIlroy M, Hill AD, Young LS.

FEBS Lett. 2011 Aug 4;585(15):2537-44. doi: 10.1016/j.febslet.2011.07.005. Epub 2011 Jul 13.

12.

HOXC11-SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib.

deBlacam C, Byrne C, Hughes E, McIlroy M, Bane F, Hill AD, Young LS.

Br J Cancer. 2011 Jun 28;105(1):118-23. doi: 10.1038/bjc.2011.193. Epub 2011 Jun 7.

13.

Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected].

McIlroy M, McCartan D, Early S, O Gaora P, Pennington S, Hill AD, Young LS.

Cancer Res. 2010 Feb 15;70(4):1585-94. doi: 10.1158/0008-5472.CAN-09-3713. Epub 2010 Feb 9. Erratum in: Cancer Res. 2010 Apr 15;70(8):3413.

14.

The role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2.

Kavanagh DO, McIlroy M, Myers E, Bane F, Crotty TB, McDermott E, Hill AD, Young LS.

Endocr Relat Cancer. 2010 Feb 18;17(1):255-64. doi: 10.1677/ERC-09-0216. Print 2010 Mar.

PMID:
20032008
15.

Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence.

Redmond AM, Bane FT, Stafford AT, McIlroy M, Dillon MF, Crotty TB, Hill AD, Young LS.

Clin Cancer Res. 2009 Mar 15;15(6):2098-106. doi: 10.1158/1078-0432.CCR-08-1649. Epub 2009 Mar 10.

16.

Cytochrome P450 1B1 expression in rat esophageal tumorigenesis promoted by gastric and duodenal reflux.

Devlin AH, McIlroy M, McKeen HD, Bonde P, Menezes AA, Swarbrick CJ, Robson T, Hirst DG, Campbell FC, McGuigan JA, McKeown SR.

Mol Carcinog. 2009 Feb;48(2):110-7. doi: 10.1002/mc.20459.

PMID:
18618592
17.

Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients.

Dillon MF, Stafford AT, Kelly G, Redmond AM, McIlroy M, Crotty TB, McDermott E, Hill AD, Young LS.

Endocr Relat Cancer. 2008 Sep;15(3):745-53. doi: 10.1677/ERC-08-0009. Epub 2008 May 9.

PMID:
18469157
18.

Pericytes influence endothelial cell growth characteristics: role of plasminogen activator inhibitor type 1 (PAI-1).

McIlroy M, O'Rourke M, McKeown SR, Hirst DG, Robson T.

Cardiovasc Res. 2006 Jan;69(1):207-17. Epub 2005 Sep 13.

PMID:
16165110
20.

Medical students' perceptions of the practice of internal medicine.

Vyskocil JJ, Whitney-Merritt K, Milliken JP, McIlroy MA.

Acad Med. 1991 Dec;66(12):747-8. No abstract available.

PMID:
1750952
21.

Pyogenic infection of the sacroiliac joint. Case reports and review of the literature.

Vyskocil JJ, McIlroy MA, Brennan TA, Wilson FM.

Medicine (Baltimore). 1991 May;70(3):188-97. Review.

PMID:
2030642
22.

Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis.

McIlroy MA.

J Infect Dis. 1991 Feb;163(2):420-1. No abstract available.

PMID:
1988531
23.

A model of the pulmonary arterial bed in adults and infants.

McIlroy MB, Hargrave VK, Targett RC.

Comput Biomed Res. 1990 Apr;23(2):130-8.

PMID:
2335071
24.

Infected false aneurysms of the femoral artery in intravenous drug addicts.

McIlroy MA, Reddy D, Markowitz N, Saravolatz LD.

Rev Infect Dis. 1989 Jul-Aug;11(4):578-85.

PMID:
2772464
25.

Aseptic meningitis complicating adult Kawasaki disease: case report and review of the literature.

McIlroy MA, Fisher EJ, Saravolatz LD, Hardwicke MB, Wilson FM.

Am J Med. 1989 Jul;87(1):106-10. Review. No abstract available.

PMID:
2662768
27.

A model of the systemic arterial bed showing ventricular-systemic arterial coupling.

McIlroy MB, Targett RC.

Am J Physiol. 1988 Mar;254(3 Pt 2):H609-16.

PMID:
3348437
28.

Dynamics of chest wall in preterm infants.

Heldt GP, McIlroy MB.

J Appl Physiol (1985). 1987 Jan;62(1):170-4.

PMID:
3558177
29.

Distortion of chest wall and work of diaphragm in preterm infants.

Heldt GP, McIlroy MB.

J Appl Physiol (1985). 1987 Jan;62(1):164-9.

PMID:
3558176
30.
31.

Doppler blood velocity in the pulmonary artery of infants, children, and adults.

Targett RC, Heldt GP, McIlroy MB.

Cardiovasc Res. 1986 Nov;20(11):816-21.

PMID:
3304640
32.

A transmission line model of the normal aorta and its branches.

McIlroy MB, Seitz WS, Targett RC.

Cardiovasc Res. 1986 Aug;20(8):581-7.

PMID:
3791347
33.

Echographic application of the Gorlin formula for assessment of aortic stenosis: correlation with cardiac catheterization in pediatric patients.

Seitz WS, McIlroy MB, Kline H, Operschall J, Kashani IA.

Am Heart J. 1986 Jun;111(6):1118-22.

PMID:
3716987
34.

Non-invasive ultrasonic cardiac output measurement in intensive care unit.

Levy BI, Payen DM, Tedgui A, Xhaard M, McIlroy MB.

Ultrasound Med Biol. 1985 Nov-Dec;11(6):841-9.

PMID:
3913083
35.

Doppler ultrasonic investigation of Raynaud's phenomenon: effect of temperature on blood velocity.

McIlroy MB, Targett RC, Roussin A, Seitz WS.

Ultrasound Med Biol. 1985 Sep-Oct;11(5):719-25.

PMID:
2932829
36.

Simultaneous Doppler blood velocity measurements from aorta and radial artery in normal human subjects.

Targett RC, Levy B, Bardou A, McIlroy MB.

Cardiovasc Res. 1985 Jul;19(7):394-9.

PMID:
3893698
37.

Quantitative ascending aortic Doppler blood velocity in normal human subjects.

Levy B, Targett RC, Bardou A, McIlroy MB.

Cardiovasc Res. 1985 Jul;19(7):383-93.

PMID:
3893697
38.

Spatial and temporal resolution of aortic Doppler blood velocity signals in normal human subjects.

Targett RC, McIlroy MB.

Ultrasound Med Biol. 1985 Jul-Aug;11(4):577-84.

PMID:
2931882
39.

Autonomic function in myotonic dystrophy.

Aminoff MJ, Beckley DJ, McIlroy MB.

Arch Neurol. 1985 Jan;42(1):16. No abstract available.

PMID:
3966879
41.

Skin gas tensions and resistances measured by mass spectrometry in adults.

Targett RC, Kocher O, Muramatsu K, McIlroy MB.

J Appl Physiol Respir Environ Exerc Physiol. 1984 May;56(5):1431-5.

PMID:
6427157
42.

An intercostal retractometer for estimation of intrapleural pressure changes in infants.

Heldt GP, Clements JA, McIlroy MB, Tooley WH.

J Appl Physiol Respir Environ Exerc Physiol. 1982 Jun;52(6):1667-71.

PMID:
7107480
43.

Comparison of methods of recording and analysis of Doppler blood velocity signals in normal subjects.

Creekmore SP, Graham MM, Jahn GE, Targett RC, McIlroy MB.

Ultrasound Med Biol. 1982;8(5):525-35.

PMID:
7147466
44.

Transfer of oxygen, nitrogen, and carbon dioxide through normal adult human skin.

Hansen TN, Sonoda Y, McIlroy MB.

J Appl Physiol Respir Environ Exerc Physiol. 1980 Sep;49(3):438-43.

PMID:
6782048
45.

Partial deficiency of carnitine palmityltransferase: physiologic and biochemical consequences.

Layzer RB, Havel RJ, McIlroy MB.

Neurology. 1980 Jun;30(6):627-33.

PMID:
7189839
46.

Exercise performance of the survivors of hyaline membrane disease.

Heldt GP, McIlroy MB, Hansen TN, Tooley WH.

J Pediatr. 1980 Jun;96(6):995-9. No abstract available.

PMID:
6768870
48.

Transcutaneous blood gas measurement using a mass spectrometer.

McIlroy MB, Simbruner G, Sonoda Y.

Acta Anaesthesiol Scand Suppl. 1978;68:128-30.

PMID:
279193
49.

On the development of new methods in cardiopulmonary physiology and medicine.

McIlroy MB.

Am Rev Respir Dis. 1977 Jun;115(6 Pt 2):143-5. No abstract available.

PMID:
869309
50.

Transient LW-negative red blood cells and anti-LW in a patient with Hodgkin's disease.

Perkins HA, McIlroy M, Swanson J, Kadin M.

Vox Sang. 1977;33(5):299-303.

PMID:
411256

Supplemental Content

Loading ...
Support Center